Myocarditis is not a "minor and transient" complication. While it is not immediately life-threatening, especially when detected early, it can have a significant

Myocarditis is not a "minor and transient" complication. While it is not immediately life-threatening, especially when detected early, it can have a significant effect on mortality risk later on. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951175/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951175/ It also often goes undetected, so the VAERS data should serve as a lower bound. > pulling from VAERS, which is problematic for a number of reasons The FDA also uses data from VAERS for its assessment: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-08-30/03-COVID-Su-508.pdf https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-...